Navigation Links
Shire plc: Results of the Annual General Meeting Held on April 28, 2009
Date:4/28/2009

DUBLIN, April 28 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that at its Annual General Meeting today, all resolutions contained in the notice of meeting were duly passed and the results of the poll are as follows:

                                        For*      Against  Withheld**
    1.     To receive the
           Company's accounts
           together with the
           director's and
           auditor's reports    385,589,148    2,271,000     26,380
    2.     To approve the
           Remuneration Report  307,647,526   60,796,610 19,442,392
    3.     To elect Dr Barry
           Price as a Director
           of the Company       356,441,471   31,425,618     19,439
    4.     To re-appoint
           Deloitte LLP as
           Auditors of the
           Company              387,555,848      311,630     19,050
    5.     To authorize the
           Audit, Compliance
           and Risk Committee
           to determine the
           remuneration of the
           Auditors             387,180,598      671,746     34,184
    6.     To authorize the
           allotment of shares  332,997,412   54,868,377     20,739
    7.     To authorize the
           disapplication of
           pre-emption rights   387,558,665      297,124     30,739
    8.     To authorize market
           purchases            387,693,316      173,212     20,000

    * These figures include discretionary votes

** A vote "withheld" is not a vote in law and is not counted in the calculation of the votes "for" or "against" a resolution.

Two copies of all resolutions passed, other than resolutions concerning ordinary business, will shortly be submitted to the UK Listing Authority and will be available for inspection at the UK Li
'/>"/>

SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Shire plc: First Quarter 2009 Results Date Notification - April 30, 2009
2. Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL(R) (lanthanum carbonate) Patents
3. Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD
4. Publication of Shire plcs Annual Report 2008
5. Shires Project Playground Gives Boost to Philadelphia
6. Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
7. Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents
8. Shire Announces Opening of Office in Japan
9. Shire to Enter European ADHD Market With the Acquisition of EQUASYM(R) IR and XL
10. Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion
11. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... (PRWEB) January 14, 2014 EquitiesIQ, a ... Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical company ... the wound care market. , Free report download: ... with a seasoned management team and Board, which launched ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo ... institutes from the National Institutes of Health (NIH) to ... more effective treatments to patients on a faster timeline. ... Translational Sciences (NCATS) and the National Eye Institute (NEI) ...
(Date:1/14/2014)... Canada (PRWEB) January 14, 2014 In ... its motives and methods in product development and promotion ... the industry. This mistrust, fueled by concerns about the ... fed by reports of spectacular fines to the world’s ...
(Date:1/14/2014)... Global Record Systems, LLC, (GRS), ... solutions for patients, physicians, the biopharmaceutical industry, regulators, ... the signing of a three-year Research Collaboration Agreement ... (FDA). This initiative is designed to generate ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
...  Cenestra Health announces that the U.S. Patent and Trademark ... No. 8,071,646 (the ",646 patent"), that protects and provides ... acid (EPA) and docosahexaenoic acid (DHA) in ratios ranging ... provides exclusivity for these EPA:DHA ratios in compositions with ...
... of up to 25 percent in two barely separated ... Designers of next-generation devices using nanowires to deliver electric ... solar arrays may need to make allowances for ... for 20 years," says Sandia lead researcher Mike Lilly. ...
... RATON, Fla., Dec. 7, 2011 /PRNewswire-iReach/ -- ... Herb Pharma, Switzerland: the best and most powerful weapons ... Although aging is a natural process, no-one ... neck and decolletage, which are on display most of ...
Cached Biology Technology:Cenestra Health Announces Granting of Broad Patent Covering Proprietary Bioactive Lipid Formulations 2Cenestra Health Announces Granting of Broad Patent Covering Proprietary Bioactive Lipid Formulations 3Voltage increases up to 25 percent observed in closely packed nanowires at Sandia Labs 2Voltage increases up to 25 percent observed in closely packed nanowires at Sandia Labs 3Fytofontana Cosmeceuticals: The Swiss Secret For Incredibly Young And Beautiful Skin 2
(Date:4/17/2014)... Sodium channels are implicated in many serious conditions such ... important potential target for drug therapies. Unfortunately, there is ... New Cambridge research provides fresh and unexpected insight into ... its components - β-subunit molecules - which are responsible ... is published in the most recent edition of the ...
(Date:4/17/2014)... genetic information of DNA is used to manufacture ... different functions in living organisms. Messenger RNA (mRNA) ... by relating the genetic information of DNA to ... , By examining the different types and amounts ... a given time, researchers can determine which specific ...
(Date:4/17/2014)... International researchers, led by the Australian National University ... sea-level changes and deep-sea temperature variability over the ... scientists better understand the climate surrounding ice ages ... help determine the relationship between carbon dioxide levels, ... ANU, the University of Southampton (UoS) and the ...
Breaking Biology News(10 mins):Structure of sodium channels different than previously believed 2Rapid and accurate mRNA detection in plant tissues 2Ancient sea-levels give new clues on ice ages 2
... has long been used topically in many skin creams ... for the skin. Now, new research just published in ... consuming flavanol-rich cocoa and how it might actually benefit ... certain components in cocoa may actually help improve the ...
... vaccines may increase elderly patients' immune response without ... protection against the flu, according to an article ... Internal Medicine, one of the JAMA/Archives journals. , ... for 50 years to prevent flu and its ...
... the Stanford University School of Medicine have taken a ... that could eventually be transplanted into living organisms. , ... resident Oscar Abilez, MD, and colleagues have successfully differentiated ... blocks of blood vessels, after placing them in a ...
Cached Biology News:New study reveals components of cocoa may enhance the appearance of the skin 2High-dose flu vaccines appear to safely boost immunity in elderly 2Stanford doctors advance in bid to turn mice stem cells into blood vessels 2Stanford doctors advance in bid to turn mice stem cells into blood vessels 3
Component of HyperMu™ Insertion Kit...
Request Info...
... x 2 , Maintenance ... /each , Immunizations/Boost injections x5 ... ml) x1 /each , Production bleed ... Final Bleed ~ 100 ml blood (~50 ml ...
... 500 g protein in ... mouse whole cell lysate; Abelson transformed macrophage ... as Western blotting positive control, ... and thawing should be minimized, ...
Biology Products: